SANUWAVE HealthvsThermo Fisher Scientific

SNWV and TMO stock compared: price, dividend, valuation and results, from SEC filings.

SNWV

SANUWAVE Health, Inc.

$1.81

Value $16M

-0.55%
SNWV's page

TMO

Thermo Fisher Scientific Inc

$691.33

Value $257B

-1.27%
TMO's page

SANUWAVE Health (SNWV) has a market value of $16M and Thermo Fisher Scientific (TMO) $257B. Over the last year, with dividends, SNWV moved -94.5% and TMO +19.9%. The P/E is 3.7 for SNWV and 36.3 for TMO. Dividend yield: SNWV none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    SNWV$16M

    TMO$257B

    TMO is 16,510 times SNWV

  • Revenue, 12 months

    SNWV$41M

    TMO$47.4B

    TMO is 1,146 times SNWV

  • Net income, 12 months

    SNWV$4.2M

    TMO$7.1B

    TMO is 1,702 times SNWV

  • Operating margin

    SNWV-1.1%

    TMO17.9%

    19.0 points apart

  • ROIC

    SNWV-2.4%

    TMO8.2%

    10.6 points apart

  • P/E

    SNWV3.7

    TMO36.3

    TMO is 9.7 times SNWV

  • Dividend yield

    SNWV0.0%

    TMO0.3%

    0.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

SNWV-94.5%

TMO+19.9%

050100DecFebAprJunAugOct
Returns by period
PeriodSNWVWith dividendsTMOWith dividends
1 year since November 14, 2025-94.5%Price -94.5%+19.9%Price +19.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

SNWVSANUWAVE HealthTMOThermo Fisher Scientific

Valuation

SNWVTMO
Valuation
Price$1.81$691.33
Market value$16M$257B
Enterprise value (EV)$26M$292B
P/E3.736.3
P/E, 5-year median–32.7
P/B5.54.7
EV/EBIT–34.5
Free cash flow yield16.7%3.0%

Results and growth

SNWVTMO
Results and growth
Revenue, 12 months$41M$47.4B
Net income, 12 months$4.2M$7.1B
Free cash flow, 12 months$2.6M$7.6B
Earnings per share, 12 months-$0.21$18.96
Revenue growth, year on year35.0%3.9%
Revenue growth a year, past+61.1%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

SNWVTMO
Margins and returns on capital
Gross margin76.2%–
Operating margin-1.1%17.9%
Net margin10.1%14.9%
ROIC-2.4%8.2%
ROE1,383.2%13.4%

Balance sheet

SNWVTMO
Balance sheet
Cash$6.6M$6.1B
Total debt$18M$41.4B
Net debt / EBITDA20.03.7
Interest cover–5.5×

Dividends and buybacks

SNWVTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: SNWV or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, SANUWAVE Health or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($257B) is about 16,509.8 times SANUWAVE Health ($16M), at today's prices.

How did SNWV and TMO stock do over the last 1 years?

Since November 14, 2025, SNWV's price moved -94.5% and TMO's +19.5%. With dividends: SNWV -94.5% (-94.5% a year), TMO +19.9% (+19.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, SNWV or TMO?

The dividend yield at today's price is none for SANUWAVE Health and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

What is the P/E of SNWV and TMO?

At today's price, the P/E is 3.7 for SNWV and 36.3 for TMO. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, SANUWAVE Health or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 10.1% for SANUWAVE Health and 14.9% for Thermo Fisher Scientific, and the operating margin -1.1% and 17.9%. Revenue was $41M and $47.4B.

Which is the better investment, SANUWAVE Health or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.